재사용 가능 인슐린 주사 펜 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 적응증별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Reusable Insulin Injector Pens Market Summary

The global reusable insulin injector pens market size was estimated at USD 5.5 billion in 2025 and is projected to reach USD 10.3 billion by 2033, growing at a CAGR of 8.1% from 2026 to 2033. This growth is driven by the increasing prevalence of diabetes, growing demand for convenient self-administration devices, and rising awareness regarding long-term diabetes management.

Reusable insulin injector pens are increasingly preferred over traditional vial-and-syringe methods because they offer improved dosing accuracy, portability, patient convenience, and lower long-term treatment costs through replaceable insulin cartridges. According to the World Health Organization (WHO), more than 830 million people worldwide are living with diabetes, with the majority residing in low- and middle-income countries, highlighting the growing need for efficient insulin delivery solutions. The market is also benefiting from the increasing preference for home-based diabetes care and self-administration practices among insulin-dependent patients.

Reusable insulin injector pens simplify insulin therapy by offering easy cartridge replacement, discreet usage, and improved adherence compared to conventional insulin administration methods. In addition, aging populations, rising obesity rates, and increasing incidence of lifestyle-related diseases are contributing to the growing number of insulin-dependent diabetic patients worldwide. Healthcare systems across developed and emerging economies are increasingly encouraging self-management solutions to reduce hospital visits and improve long-term disease monitoring, further supporting the adoption of reusable insulin injector pens.

One of the major factors driving market growth is the rapid adoption of smart reusable insulin pens integrated with Bluetooth connectivity, mobile applications, and continuous glucose monitoring (CGM) systems. Manufacturers are increasingly focusing on connected diabetes management ecosystems that enable real-time dose tracking, personalized insulin recommendations, and remote monitoring. For instance, Medtronic announced the commercial launch of its MiniMed Go Smart MDI system in Europe, integrating the reusable InPen smart insulin pen with Simplera CGM technology through a single mobile application. The system provides real-time glucose insights, dose reminders, and advanced dose calculations for patients using multiple daily insulin injections.

The market is also benefiting from the increasing preference for home-based diabetes care and self-administration practices among insulin-dependent patients. Reusable insulin injector pens simplify insulin therapy by offering easy cartridge replacement, discreet usage, and improved adherence compared to conventional insulin administration methods. In addition, aging populations, rising obesity rates, and increasing incidence of lifestyle-related diseases are contributing to the growing number of insulin-dependent diabetic patients worldwide. Healthcare systems across developed and emerging economies are increasingly encouraging self-management solutions to reduce hospital visits and improve long-term disease monitoring, further supporting the adoption of reusable insulin injector pens.

Sustainability and cost efficiency are also becoming important factors supporting market expansion. Compared to disposable insulin pens, reusable insulin injector pens generate less medical waste and offer lower long-term therapy costs because patients only need to replace insulin cartridges instead of the entire device. This is particularly important in emerging economies where affordability remains a key concern in diabetes treatment. Governments and healthcare providers are increasingly focusing on sustainable healthcare practices and cost-effective chronic disease management solutions, which is encouraging the shift toward reusable insulin delivery systems. Furthermore, increasing penetration of retail pharmacies, e-commerce healthcare platforms, and diabetes specialty clinics is improving product accessibility across the regions.

Global Reusable Insulin Injector Pens Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the global reusable insulin injector pens market report based on type, indication, end use, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Mechanical Pens
• Smart/Connected Pens
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Type 1 Diabetes
• Type 2 Diabetes
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Homecare
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • China
  • Japan
  • South Korea
  • Thailand
  • Australia
  • India
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Indication
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Indication outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Reusable Insulin Injector Pens Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Reusable Insulin Injector Pens Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Reusable Insulin Injector Pens Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Reusable Insulin Injector Pens Market: Type Movement Analysis
• 4.3. Reusable Insulin Injector Pens Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Mechanical Pens
  • 4.5.1. Mechanical Pens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Smart/Connected Pens
  • 4.6.1. Smart/Connected Pens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Reusable Insulin Injector Pens Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Reusable Insulin Injector Pens Market: Indication Movement Analysis
• 5.3. Reusable Insulin Injector Pens Market by Indication Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Type 1 Diabetes
  • 5.5.1. Type 1 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Type 2 Diabetes
  • 5.6.1. Type 2 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Reusable Insulin Injector Pens Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Reusable Insulin Injector Pens Market: End Use Movement Analysis
• 6.3. Reusable Insulin Injector Pens Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Hospitals & Clinics
  • 6.5.1. Hopsital & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Homecare
  • 6.6.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Reusable Insulin Injector Pens Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Reusable Insulin Injector Pens Market Movement Analysis
• 7.3. Reusable Insulin Injector Pens Market: Regional Estimates & Trend Analysis by Product & Age Group
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. North America
  • 7.5.1. North America Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. UK Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Germany Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. France Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Italy Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Spain Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Denmark Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Sweden Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.9. Norway
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Competitive Scenario
    • 7.6.9.3. Regulatory Framework
    • 7.6.9.4. Reimbursement scenario
    • 7.6.9.5. Norway Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Japan Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. China Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. India Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Australia Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Thailand Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Brazil Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. South Africa Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Saudi Arabia Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. UAE Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Reimbursement scenario
    • 7.9.5.5. Kuwait Reusable Insulin Injector Pens Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Novo Nordisk
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Product Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. Sanofi
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Product Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. Eli Lilly and Company
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Product Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. Ypsomed AG
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Product Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. Medtronic
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Product Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. Biocon Biologics
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Product Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. Haselmeier GmbH
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Product Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. Emperra GmbH E-Health Technologies
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Product Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Pendiq GmbH
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Product Benchmarking
    • 8.2.9.4. Strategic Initiatives
  • 8.2.10. Owen Mumford Ltd.
    • 8.2.10.1. Company Overview
    • 8.2.10.2. Financial Performance
    • 8.2.10.3. Product Benchmarking
    • 8.2.10.4. Strategic Initiatives
  • 8.2.11. Wockhardt Ltd.
    • 8.2.11.1. Company Overview
    • 8.2.11.2. Financial Performance
    • 8.2.11.3. Product Benchmarking
    • 8.2.11.4. Strategic Initiatives